J.MarkusCarterDO

PubMed

• An audit of platelet transfusion within the Wellington Cancer Centre.
  Buhrkuhl, D. C., Karlsson, M. K., Carter, J. M.> ;Intern Med J. 2012 Jan
• 19 citations
  Microbead-based immunoassay for simultaneous detection of Shiga toxins and isolation of Escherichia coli O157 in foods.
  Laurie M. Clotilde, Clay Bernard, Gary L. Hartman, David K. Lau, J. Mark Carter> ;Journal of Food Protection. 2011 Mar 1
• Assessing the role of oxidized methionine at position 213 in the formation of prions in hamsters.
  Silva, C. J., Onisko, B. C., Dynin, I., Erickson, M. L., Vensel, W. H., Requena, J. R., Antaki, E. M., Carter, J. M.> ;Biochemistry. 2010 Mar 9
• Validation of a cell-free translation assay for detecting shiga toxin 2 in bacterial culture.
  He, X., Quiñones, B., Carter, J. M., Mandrell, R. E.> ;J Agric Food Chem. 2009 Jun 10
• Effect of food matrices on the biological activity of ricin.
  He, X., Lu, S., Cheng, L. W., Rasooly, R., Carter, J. M.> ;J Food Prot. 2008 Oct 01
• Detection of botulinum neurotoxin-A activity in food by peptide cleavage assay.
  Rasooly, R., Stanker, L. H., Carter, J. M., Do, P. M., Cheng, L. W., He, X., Brandon, D. L.> ;Int J Food Microbiol. 2008 Aug 15
• 39 citations
  Effects of purification on the bioavailability of botulinum neurotoxin type A.
  Luisa W. Cheng, Bruce Onisko, Eric A. Johnson, J. Rachel Reader, Stephen M Griffey, Ann E. Larson, William H. Tepp, Larry H. Stanker, David L. Brandon, J. Mark Carter> ;Toxicology. 2008 Jul 30
• Sonication induced intermediate in prion protein conversion.
  Zukas, A. A., Bruederle, C. E., Carter, J. M.> ;Protein Pept Lett. 2008
• Prion infected meat-and-bone meal is still infectious after biodiesel production.
  Bruederle, C. E., Hnasko, R. M., Kraemer, T., Garcia, R. A., Haas, M. J., Marmer, W. N., Carter, J. M.> ;PLoS One. 2008
• Sensitive, preclinical detection of prions in brain by nanospray liquid chromatography/tandem mass spectrometry.
  Onisko, B. C., Silva, C. J., Dynin, I., Erickson, M., Vensel, W. H., Hnasko, R., Requena, J. R., Carter, J. M.> ;Rapid Commun Mass Spectrom. 2007
• Application of a real time polymerase chain reaction method to detect castor toxin contamination in fluid milk and eggs.
  He, X., Carter, J. M., Brandon, D. L., Cheng, L. W., McKeon, T. A.> ;J Agric Food Chem. 2007 Aug 22
• Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS.
  Onisko, B., Dynin, I., Requena, J. R., Silva, C. J., Erickson, M., Carter, J. M.> ;J Am Soc Mass Spectrom. 2007 Jun
• Detection of castor contamination by real-time polymerase chain reaction.
  He, X., Brandon, D. L., Chen, G. Q., McKeon, T. A., Carter, J. M.> ;J Agric Food Chem. 2007 Jan 24
• A case of sporadic radiation pneumonitis.
  Lo, M. K., Iupati, D., Quddus, Z., Carter, J., Chander, S.> ;Am J Clin Oncol. 2006 Dec
• Class II HLA allele polymorphism: DRB1, DQB1 and DPB1 alleles and haplotypes in the New Zealand Maori population.
  Tracey, M. C., Carter, J. M.> ;Tissue Antigens. 2006 Oct
• PV-1 labels trans-cellular openings in mouse endothelial cells and is negatively regulated by VEGF.
  Hnasko, R., Carter, J. M., Medina, F., Frank, P. G., Lisanti, M. P.> ;Cell Cycle. 2006 Sep
• Cardiopulmonary bypass surgery in a patient with paroxysmal nocturnal haemoglobinuria.
  Dinesh, D., Baker, B., Carter, J. M.> ;Transfus Med. 2006 Jun
• New Zealand cancer patients should have access to erythropoietin treatment.
  Carter, J., Clay, J.> ;N Z Med J. 2006
• Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies.
  Ritchie, D., Hermans, I., Yang, J., Walton, J., Matthews, K., Carter, J., Findlay, M., Dady, P., Rawson, P., Ronchese, F.> ;Leuk Lymphoma. 2006 Apr
• Ethnicity variables in the incidence rates of leukemias in New Zealand populations: implications for stem-cell transplantation.
  Tracey, M. C., Carter, J. M.> ;Am J Hematol. 2005 Jun
• B cell epitope mapping using synthetic peptides.
  Carter, J. M., Loomis-Price, L.> ;Curr Protoc Immunol. 2004 May
• Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care.
  Dunn, A., Carter, J., Carter, H.> ;J Pain Symptom Manage. 2003 Dec
• Production of anti-peptide antisera.
  Carter, J. M.> ;Curr Protoc Immunol. 2003 Aug
• Severe congenital Factor VII deficiency associated with the 13q deletion syndrome.
  Hewson, M. P., Carter, J. M.> ;Am J Hematol. 2002 Nov
• HLA-DRB1 and HLA-DQB1 polymorphisms in Pacific Islands populations.
  Velickovic, Z. M., Delahunt, B., Carter, J. M.> ;Tissue Antigens. 2002 May
• Join now to see all